tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Zhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
Company AnnouncementsZhaoke Ophthalmology’s NVK002 Gains NMPA Acceptance for Myopia Treatment
8d ago
6622
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
PremiumCompany Announcements
Zhaoke Ophthalmology Updates Nomination Committee in Governance Code Compliance
15d ago
6622
Zhaoke Ophthalmology Announces Board Composition and Roles
PremiumCompany Announcements
Zhaoke Ophthalmology Announces Board Composition and Roles
15d ago
6622
Zhaoke Ophthalmology Establishes Nomination Committee for Board Appointments
PremiumCompany Announcements
Zhaoke Ophthalmology Establishes Nomination Committee for Board Appointments
17d ago
6622
Zhaoke Ophthalmology’s TAB014 BLA Accepted by China’s NMPA
PremiumCompany Announcements
Zhaoke Ophthalmology’s TAB014 BLA Accepted by China’s NMPA
1M ago
6622
FDA Clears Zhaoke Ophthalmology’s IND Application for CsA Ophthalmic Gel
PremiumCompany AnnouncementsFDA Clears Zhaoke Ophthalmology’s IND Application for CsA Ophthalmic Gel
1M ago
6622
Zhaoke Ophthalmology’s CsA Ophthalmic Gel NDA Accepted by NMPA
Premium
Company Announcements
Zhaoke Ophthalmology’s CsA Ophthalmic Gel NDA Accepted by NMPA
2M ago
6622
Zhaoke Ophthalmology Ltd. Successfully Concludes AGM with All Resolutions Passed
Premium
Company Announcements
Zhaoke Ophthalmology Ltd. Successfully Concludes AGM with All Resolutions Passed
2M ago
6622
Zhaoke Ophthalmology Announces AGM with Key Resolutions on Share Management
PremiumCompany Announcements
Zhaoke Ophthalmology Announces AGM with Key Resolutions on Share Management
3M ago
6622
Zhaoke Ophthalmology Begins Phase III Trial for Innovative Dry Eye Treatment
PremiumCompany Announcements
Zhaoke Ophthalmology Begins Phase III Trial for Innovative Dry Eye Treatment
3M ago
6622
Zhaoke Ophthalmology Expands into Thailand with New Distribution Agreements
PremiumCompany Announcements
Zhaoke Ophthalmology Expands into Thailand with New Distribution Agreements
3M ago
6622
Zhaoke Ophthalmology Advances Presbyopia Treatment with New Trials and Partnerships
PremiumCompany Announcements
Zhaoke Ophthalmology Advances Presbyopia Treatment with New Trials and Partnerships
3M ago
6622
Zhaoke Ophthalmology Renews Lease Agreement with Lee’s Pharmaceutical
PremiumCompany AnnouncementsZhaoke Ophthalmology Renews Lease Agreement with Lee’s Pharmaceutical
4M ago
6622
Zhaoke Ophthalmology Partners with AFT Pharmaceuticals to Launch Presbyopia Treatment
Premium
Company Announcements
Zhaoke Ophthalmology Partners with AFT Pharmaceuticals to Launch Presbyopia Treatment
6M ago
6622
Zhaoke Ophthalmology Makes Strides with Myopia Drug
Premium
Company Announcements
Zhaoke Ophthalmology Makes Strides with Myopia Drug
7M ago
6622
Zhaoke Ophthalmology Reports Positive Trial Results for TAB014
PremiumCompany Announcements
Zhaoke Ophthalmology Reports Positive Trial Results for TAB014
7M ago
6622
Zhaoke Ophthalmology Expands Glaucoma Drug Portfolio
PremiumCompany Announcements
Zhaoke Ophthalmology Expands Glaucoma Drug Portfolio
7M ago
6622
Zhaoke Ophthalmology Reports Success in Myopia Trial
PremiumCompany Announcements
Zhaoke Ophthalmology Reports Success in Myopia Trial
9M ago
6622
Zhaoke Ophthalmology Completes Major Drug Trial
PremiumCompany Announcements
Zhaoke Ophthalmology Completes Major Drug Trial
10M ago
6622
Zhaoke Ophthalmology Launches Preservative-Free Glaucoma Drug
PremiumCompany AnnouncementsZhaoke Ophthalmology Launches Preservative-Free Glaucoma Drug
10M ago
6622
Zhaoke Ophthalmology Narrows Losses in 2024
Premium
Company Announcements
Zhaoke Ophthalmology Narrows Losses in 2024
11M ago
6622
Zhaoke Ophthalmology Plans Key Financial Review
Premium
Company Announcements
Zhaoke Ophthalmology Plans Key Financial Review
11M ago
6622

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >